185 related articles for article (PubMed ID: 3261313)
1. Effect of the elapsed time after the final antigen boost on the specificity of monoclonal antibodies produced by B cell hybridomas.
Bazin R; Lemieux R
J Immunol Methods; 1988 Aug; 112(1):53-6. PubMed ID: 3261313
[TBL] [Abstract][Full Text] [Related]
2. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC
J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a chicken X chicken hybridoma secreting specific antibody.
Nishinaka S; Matsuda H; Murata M
Int Arch Allergy Appl Immunol; 1989; 89(4):416-9. PubMed ID: 2793228
[TBL] [Abstract][Full Text] [Related]
4. Mouse monoclonal antibodies with anti-A, anti-B and anti-A,B specificities; some superior to human polyclonal ABO reagents.
Messeter L; Brodin T; Chester MA; Löw B; Lundblad A
Vox Sang; 1984; 46(4):185-94. PubMed ID: 6369781
[TBL] [Abstract][Full Text] [Related]
5. Negative effect of multiple antigen injections on the yield of murine monoclonal antibodies obtained by hybridoma technology.
Néron S; Lemieux R
Hybridoma; 1992 Oct; 11(5):639-44. PubMed ID: 1459586
[TBL] [Abstract][Full Text] [Related]
6. In vitro B-lymphocyte antigen priming against both non-immunogenic and immunogenic molecules requiring low amounts of antigen and applicable in hybridoma technology.
Brams P; Pettijohn DE; Brown M; Olsson L
J Immunol Methods; 1987 Apr; 98(1):11-22. PubMed ID: 2435806
[TBL] [Abstract][Full Text] [Related]
7. Hybridomas specific for carbohydrates; synthetic human blood group antigens for the production, selection, and characterization of monoclonal typing reagents.
Bundle DR; Gidney MA; Kassam N; Rahman AF
J Immunol; 1982 Aug; 129(2):678-2. PubMed ID: 6177774
[TBL] [Abstract][Full Text] [Related]
8. Antigen-based immunofluorescence analysis of B-cell targeting: advanced technology for the generation of novel monoclonal antibodies with high efficiency and selectivity.
Tomita M; Fukuda T; Ozu A; Kimura K; Tsong TY; Yoshimura T
Hybridoma (Larchmt); 2006 Oct; 25(5):283-92. PubMed ID: 17044784
[TBL] [Abstract][Full Text] [Related]
9. Immunological characterization of blood group A epitopes expressed on cells and tissues with a monoclonal anti-CEA antibody.
Fiszman G; Koss A; Glait H; Horenstein A
Haematologica; 1994; 79(2):112-8. PubMed ID: 7520408
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Bcl-2/B cell transgenic mice (B6) for hybridoma production.
Knott CL; Reed JC; Bodrug S; Saedi MS; Kumar A; Kuus-Reichel K
Hybridoma; 1996 Oct; 15(5):365-71. PubMed ID: 8913786
[TBL] [Abstract][Full Text] [Related]
11. [Production of monoclonal antibody with anti-B specificity, to be used as reagent for blood classification].
León G; Cruz C; Rojas L
Invest Clin; 2004 Jun; 45(2):145-57. PubMed ID: 15211982
[TBL] [Abstract][Full Text] [Related]
12. Study of blood group B antigen with a specific monoclonal antibody (anti-B, b-183).
Rouger P; Edelman L; Doinel C; Reviron J; Salmon C; Bach JF
Immunology; 1983 May; 49(1):77-82. PubMed ID: 6840810
[TBL] [Abstract][Full Text] [Related]
13. Single-shot plasmid DNA intrasplenic immunization for the production of monoclonal antibodies. Persistent expression of DNA.
Velikovsky CA; Cassataro J; Sanchez M; Fossati CA; Fainboim L; Spitz M
J Immunol Methods; 2000 Oct; 244(1-2):1-7. PubMed ID: 11033013
[TBL] [Abstract][Full Text] [Related]
14. Human monoclonal anti-keyhole limpet hemocyanin antibody-secreting hybridoma produced from peripheral blood B lymphocytes of a keyhole limpet hemocyanin-immune individual.
Lane HC; Shelhamer JH; Mostowski HS; Fauci AS
J Exp Med; 1982 Jan; 155(1):333-8. PubMed ID: 6976416
[TBL] [Abstract][Full Text] [Related]
15. The use of an anti-CD40 agonist monoclonal antibody during immunizations enhances hybridoma generation.
Rycyzyn MA; Staquet K; Fisher J; Bannish G; Bassiri A; Duchala C; Giles-Komar J
Hybridoma (Larchmt); 2008 Feb; 27(1):25-30. PubMed ID: 18294073
[TBL] [Abstract][Full Text] [Related]
16. Rapid generation of monoclonal antibody-secreting hybridomas against African horse sickness virus by in vitro immunization and the fusion/cloning technique.
Stäuber N; Kihm U; McCullough KC
J Immunol Methods; 1993 May; 161(2):157-68. PubMed ID: 8505546
[TBL] [Abstract][Full Text] [Related]
17. [Production of monoclonal antibodies specific for the ABO blood group and rhesus D antigens].
Raache R; Rapaille A; Sondag-Thull D; Abbadi MC
Arch Inst Pasteur Alger; 1998; 62():118-37. PubMed ID: 11256302
[TBL] [Abstract][Full Text] [Related]
18. An efficient immunization protocol for production of monoclonal antibodies against soluble human insulin.
Allauzen S; Salhi SL; Piechaczyk M; Bastide M; Pau B; Bouanani M
Immunol Lett; 1994 Apr; 40(1):1-6. PubMed ID: 7927507
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody to blood group glycosyltransferases, produced by hybrids constructed with Epstein-Barr-virus-transformed B lymphocytes from a patient with ABO-incompatible bone marrow transplant and mouse myeloma cells.
Kominato Y; Fujikura T; Shimada I; Takizawa H; Hayashi K; Mori T; Matsuda T
Vox Sang; 1990; 59(2):116-8. PubMed ID: 2173279
[TBL] [Abstract][Full Text] [Related]
20. Modifications of hybridoma technology which improve the yield of monoclonal antibody producing cells.
Orlik O; Altaner C
J Immunol Methods; 1988 Nov; 115(1):55-9. PubMed ID: 2848072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
